Key takeaways
Foundayo (orforglipron) and Saxenda (liraglutide) are both medications used for weight loss and long-term weight management. They belong to the same drug class, GLP-1 agonists, which help control appetite and slow digestion. However, they differ in their administration and availability. Foundayo is an oral tablet taken once daily, while Saxenda is a subcutaneous injection also taken once daily. Foundayo is only approved for adults, whereas Saxenda can be used by adults and children aged 12 and older. Saxenda has a generic version available, while Foundayo does not. Common side effects for both include nausea, vomiting, and diarrhea, but Saxenda may also cause injection site reactions. Both medications carry a potential risk for thyroid cancer and are not recommended for individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.
